Which indications for endoscopic treatments?;Quelles sont les indications des traitements endoscopiques?

Gastroenterologie Clinique et Biologique

Volumn 28, Issue SPEC. ISS. 2, 2004, Pages

  Nevens, Frederik ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIVE AGENT; VASOACTIVE AGENT; VASOCONSTRICTOR AGENT;

CONFERENCE PAPER; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER CIRRHOSIS; PROGNOSIS; RISK ASSESSMENT; TREATMENT INDICATION; VEIN LIGATION; ACUTE DISEASE; ESOPHAGOSCOPY; ESOPHAGUS DISEASE; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; MULTIMODALITY CANCER THERAPY; REVIEW; RUPTURE;

ACUTE DISEASE; COMBINED MODALITY THERAPY; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGEAL DISEASES; ESOPHAGOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HUMANS; RUPTURE, SPONTANEOUS; VASOCONSTRICTOR AGENTS;

EID: 16544362103     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. D'Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003;124:1277-91.
2. Goulis J, Burroughs AK. Portal hypertensive bleeding: prevention and treatment. In Evidence based Gastroenterology and Hepatology eds McDonald J, Burroughs AK, Feagan B. London, BMJ Books 1999:389-426.
3. de Franchis R, Primignani M. Endoscopic treatments for protal hypertension. Seminars in liver disease 1999;19:439-55.
4. Banares R, Albillos A, Rincon D, Alonso S, Gonzalez M, Ruiz-del-Arbol L, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002;35:609-15.
5. Levacher S, Letoumelin P, Pateron D, Blaise M, Lapandry C, Pourriat JL. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995;346:865-8.
6. Avgerinos A, Nevens F, Raptis S, Fevery J. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Varciceal Episodes (ABOVE) randomized trial. Lancet 1997;350:1495-9.
7. Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. French Club for the Study of Portal Hypertension. N Engl J Med 2001;344:23-8.
8. Mitchell K, Theodossi A, Williams R. Endoscopy in patients with portal hypertension and upper gastrointestinal bleeding. Variceal Bleeding. London Pitman, 1982:62-7.
9. Siringo S, McCormick PA, Mistry P, Kaye G, McIntyre N, Burroughs AK. Prognostic significance of the white nipple sign in variceal bleeding. Gastrointestest Endosc 1991;37:51-5.
10. de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, et al. Definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 1992;15:256-61.
11. Hou MC, Lin HC, Kuo BI, Lee FY, Schmidt CM, Lee SD. Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage. Am J Gastroent 1996;91:2103-9.
12. Ben-Ari Z, Cardin F, McCormick PA, Wannamethee G, Burroughs AK. A predictive model for failure to control bleeding during acute variceal hemorrhage. J Hepatol 1999;31:443-50.
13. Moitinho E, Planas R, Banares R, Albillos A, Ruiz-del-Arbol L, Galvez C, et al. Multicenter randomized controlled trial comparing different schedules of somatostatin in the threatment of acute variceal bleeding. J Hepatology 2001;35:712-8.
14. Hartigan PM, Gebhard RL, Gregory PB. For the veterans cooperative variceal sclerotherapy group. Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis. Gastrointestinal Endoscopy 1997;46:1-7.
15. Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527-32.
16. Laine L, el-Newihi HM, Migikovsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices. Ann Intern Med 1993;119:1-7.
17. Hou MV, Lin HC, Kuo BI, Chen CH, Lee FY, Lee SD. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: a prospective randomized trial. Hepatology 1995;21:1517-22.
18. Lo GH, Lai KH, Cheng JS, Lin CK, Huang JS, Hsu PI, et al. Emergency banding ligation versus sclerotherapy for the control of bleeding from esophageal varices. Hepatology 1997;25:1101-4.
19. Young MF, Sanowski RA, Rasche R. Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc 1993;39:119-22.
20. Singal A, Sarin S, Sood G, Broor S. Ulcers after intravariceal sclerotherapy: correlation of symptoms and factors affecting healing. J Clin Gastroenterol 1990;12:250-4.
21. Hou MC, Yen TC, Lin HC, Kuo BI, Chen CH, Lee FY, et al. Sequential changes of esophageal motility after endoscopic injection sclerotherapy or variceal ligation for esophageal variceal bleeding: a scintigraphic study. Am J Gastroenterol 1997;92:1875-8.
22. Kulkarni SG, Parikh SS, Dhawan PS, Chachad H, Jambavalikar MB. High frequency of bacteremia with endoscopic treatment of esophageal varices in advanced cirrhosis. Ind J Gastroenterol 1999;18:143-5.
23. Yoshikawa I, Murata I, Nakano S, Otsuki M. Effects of endoscopic variceal ligation on portal hypertensive gastropathy and gastric mucosal blood flow. Am J Gastroenterol 1998;93:71-4.
24. Zimmer T, Rucktaschel F, Stolzel U, Liehr RM, Schuppan D, Stallmach A, et al. Endoscopic sclerotherapy with fibrin glue as compared with polidocanol to prevent early esophageal variceal rebleeding. J Hepatol 1998;28:292-7.
25. Sung JJ, Yeo W, Suen R, Lee YT, Chung SC, Chan FK, et al. Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate. Gastrointest Endosc 1998;47:235-9.
26. Maluf-Filho F, Sakai P, Ishioka S, Matuguma SE. Endoscopic sclerosis versus cyanoacrylate endoscopic injection for the first episode of variceal bleeding: a prospective, controlled, and randomized study in Child-Pugh class C patients. Endoscopy 2001;33:421-7.
27. Feretis C, Dimopoulos C, Benakis P, Kalliiakmanis B, Apostolidis N. N-butyl-2-cyanooacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study. Endoscopy 1995;27:355-7.
28. Thakeb F, Salama Z, Salama H, Abdel Raouf T, Abdel Kader S, Abdel Hamid H. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices. Endoscopy 1995;27:358-64.
29. Burroughs AK and the International Octreotide Varices Study Group. Double blind RCT of 5-day octreotide versus placebo, associated with sclerotherapy for trial/failures (Abstract). Hepatology 1996;24:352A.
30. Sung JJY, Chung S, Yung MY, Lai CW, Lau JY, Lee Yt, et al. Prospective randomized study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995;346:1666-9.
31. Zuberi BF, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis. Am J Gastroenterol 2000;95:768-71.
32. Besson I, Ingrand P, Person B, Boutroux D, Heresbach D, Bernard P, et al. Sclerotherapy with ot without octreotide for active variceal bleeding. N Engl J Med 1995;333:555-60.
33. Burroughs AK. Assessment of value of consensus definition in acute variceal bleeding. Lancet 2001;357:1147-8.
34. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332-54.